Microbial pathogenesis of Mycobacterium tuberculosis: Dawn of a discipline

Cell

Volumn 104, Issue 4, 2001, Pages 477-485

  Glickman, Michael S ^a   Jacobs Jr , William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOME; GENOTYPE; HUMAN; LIPID METABOLISM; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; TUBERCULOSIS;

MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0035936760     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(01)00236-7     Document Type: Review

References (79)

1. Mechanisms of phagocytosis in macrophages
2. Mendelian susceptibility to mycobacterial infection in man
3. Response of cultured macrophages to Mycobacterium tuberculosis with observation on fusion of lysosomes with phagosomes
4. Metabolism of mycobacteria in tissues
5. Conditionally replicating mycobacteriophages: A system for transposon delivery to Mycobacterium tuberculosis
6. Mycobacterium
7. Mycolic acids: Structure, biosynthesis and physiological functions
8. Trafficking and release of mycobacterial lipids from infected macrophages
9. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene
10. The envelope of mycobacteria
11. Genomics, biology, and evolution of the Mycobacterium tuberculosis complex
12. Identification of a virulence gene cluster of Mycobacterium tuberculosis by signature-tagged transposon mutagenesis
13. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages
14. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
15. Structural basis of capacity of lipoarabinomannan to induce secretion of tumor necrosis factor
16. Two-carbon compounds and fatty acids as carbon sources
17. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited
18. Deviant expression of Rab5 on phagosomes containing the intracellular pathogens Mycobacterium tuberculosis and Legionella pneumophila is associated with altered phagosomal fate
19. A 62-dose, 6-month therapy for pulmonary and extrapulmonary tuberculosis. A twice-weekly, directly observed, and cost-effective regimen
20. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence
21. Disseminated tuberculosis in interferon gamma gene-disrupted mice
22. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis
23. Cellular microbiology emerging
24. Controlled clinical trial of four short-course (6 month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Third report
25. Complex lipid determines tissue-specific replication of Mycobacterium tuberculosis in mice
26. The envelope layers of mycobacteria with reference to their pathogenicity
27. Rabbit model of tuberculosis
28. Oxygenated mycolic acids are necessary for virulence of mycobacterium tuberculosis in mice
29. Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country
30. Macrophage receptors for Mycobacterium tuberculosis
31. A coat protein on phagosomes involved in the intracellular survival of mycobacteria
32. Exploitation of mammalian host cell functions by bacterial pathogens
33. Common themes in microbial pathogenicity revisited
34. An acyl-CoA synthase (acoas) gene adjacent to the mycocerosic acid synthase (mas) locus is necessary for mycocerosyl lipid synthesis in Mycobacterium tuberculosis var. bovis BCG
35. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
36. Essential role for cholesterol in entry of mycobacteria into macrophages
37. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans cyclopropane synthetase
38. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis
39. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS)
40. Characterization of activity and expression of isocitrate lyase in Mycobacterium avium and Mycobacterium tuberculosis
41. Expression of Mycobacterium leprae genes from a Streptococcus mutans promoter in Escherichia coli K-12
42. Introduction of foreign DNA into mycobacteria using a shuttle phasmid
43. A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection
44. Purification and characterization of acyl coenzyme A synthetase from Escherichia coli
45. Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells
46. Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis
47. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs
48. In vivo growth characteristics of leucine and methionine auxotrophic mutants of Mycobacterium bovis BCG generated by transposon mutagenesis
49. Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase
50. Persisting problems in Tuberculosis
51. Guinea pig model of Tuberculosis
52. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection
53. Role of the cell wall phenolic glycolipid-1 in the peripheral nerve predilection of Mycobacterium leprae
54. In vivo induction of apoptosis in the thymus by administration of mycobacterial cord factor (trehalose 6,6′-dimycolate)
55. Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange
56. Efficient allelic exchange and transposon mutagenesis in Mycobacterium tuberculosis
57. Generation of unmarked directed mutations in mycobacteria, using sucrose counter-selectable suicide vectors
58. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type
59. Granuloma-specific expression of Mycobacterium virulence proteins from the glycine-rich PE-PGRS family
60. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts
61. Depletion of CD4(+) T cells causes reactivation of murine persistent tuberculosis despite continued expression of interferon gamma and nitric oxide synthase 2
62. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro
63. Inhibition of interferon-gamma-mediated activation in mouse macrophages treated with lipoarabinomannan
64. Mycobacterial lipoarabinomannan inhibits gamma interferon-mediated activation of macrophages
65. Lysogeny and transformation in mycobacteria: Stable expression of foreign genes
66. Cord factor (alpha,alpha-trehalose 6,6′-dimycolate) inhibits fusion between phospholipid vesicles
67. An antimicrobial activity of cytolytic T cells mediated by granulysin
68. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase
69. Suppression of monocyte oxidative response by phenolic glycolipid I of Mycobacterium leprae
70. Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7
71. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions
72. Use of carbon sources for lipid biosynthesis in Mycobacterium leprae: A comparison with other pathogenic mycobacteria
73. Dissection of Mycobacterium tuberculosis antigens using recombinant DNA
74. Genes for the major protein antigens of the leprosy parasite Mycobacterium leprae